首页> 外国专利> NEUSSERIA PERFLAVA ALLERGEN, METHOD TO PREDICT SENSITIVITY TO NEUSSERIA PERFLAVA AND METHOD OF IMMUNOTHERAPY IN PATIENTS WITH INFECTIOUS- ALLERGIC DISEASES

NEUSSERIA PERFLAVA ALLERGEN, METHOD TO PREDICT SENSITIVITY TO NEUSSERIA PERFLAVA AND METHOD OF IMMUNOTHERAPY IN PATIENTS WITH INFECTIOUS- ALLERGIC DISEASES

机译:奈瑟氏球菌过敏原,预测奈瑟氏球菌敏感性的方法和感染性疾病患者的免疫治疗方法

摘要

FIELD: medicine, immunology. SUBSTANCE: Neusseria perflava allergen is suggested representing the mixture of phenol-inactivated microbial cells of "57" and "11" strains and products of their metabolism at 300-500 mln microbial cells/ml concentration, pH = 6.5-7.3. The present allergen could be used for specific diagnostics to Neusseria perflava and in immunotherapeutic methods in patients suffering infectious-allergic diseases. EFFECT: increased sensitivity level to Neusseria perflava and higher efficiency to conduct specific immunotherapy. 3 cl, 5 tbl
机译:领域:医学,免疫学。物质:建议将新孢子虫变应原变应原表示“ 57”和“ 11”菌株的苯酚灭活微生物细胞及其代谢产物在300-500百万微生物细胞/ ml浓度(pH = 6.5-7.3)下的混合物。本发明的过敏原可被用于perfneusneuseria的特异性诊断,并用于感染性过敏性疾病患者的免疫治疗方法。效果:提高了对新孢子虫的敏感性水平,并提高了进行特异性免疫疗法的效率。 3厘升,5汤匙

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号